RecruitingNCT03943316
Prospective Laboratory Study Biologic Specimens and Tumor Tissue of Patients With Cancer
Single Institution (UNM) Prospective Laboratory Study Biologic Specimens and Tumor Tissue of Patients With Cancer
Sponsor
New Mexico Cancer Research Alliance
Enrollment
500 participants
Start Date
Dec 2, 2015
Study Type
OBSERVATIONAL
Conditions
Summary
Ascites samples from women undergoing surgery for ovarian cancer will be collected for use in translational research.
Eligibility
Sex: FEMALEMin Age: 18 Years
Plain Language Summary
Simplified for easier understanding
This is a laboratory research study that collects fluid from the abdomen (called ascites fluid) during surgery for ovarian cancer. Researchers will use this fluid to study cancer cells and immune cells, and to test experimental therapies in the lab — not directly on patients. The goal is to discover new treatment approaches for ovarian cancer.
**You may be eligible if...**
- You are a woman undergoing surgery to remove ovarian cancer tumors (cytoreductive surgery)
- You are 18 years or older
- You are suspected or confirmed to have ovarian cancer
- You are willing to have your ascites fluid collected and used for research
**You may NOT be eligible if...**
- You are under 18 years old
- You are unwilling to consent to tissue/fluid donation for research
- You do not have a diagnosis or strong clinical suspicion of ovarian cancer
Talk to your doctor to see if this trial is right for you.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT03943316
Related Trials
Fecal Microbiota Transplantation in Treating Immune-Checkpoint Inhibitor Induced-Diarrhea or Colitis in Genitourinary Cancer Patients
NCT040386191 location
A Clinical Trial of Sac-TMT in People With Non-HRD Positive Advanced Ovarian Cancer (MK-2870-021)
NCT07318558135 locations
BI-1808 as a Single Agent and With Pembrolizumab (KEYTRUDA® ) in Treatment of Advanced Malignancies(Keynote-D20)
NCT0475282625 locations
A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations
NCT0710972615 locations
A Study of DC05F01 in Chinese Patients With Recurrent/Refractory Ovarian Cancer and Other Advanced Solid Tumors
NCT068735552 locations